Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 524,580	$ 868,067
Short-term investment	39,364	39,249
Accounts receivable, net	674,694	284,395
Costs and estimated earnings in excess of billings on uncompleted contracts	324,370	36,476
Inventory	212,925	48,011
Prepaid expenses and other current assets	9,493	1,405
Total current assets	1,785,426	1,277,603
Equipment, net	12,718	6,064
Security deposit	12,000
Debt issuance costs, net	67,245	103,632
Totals	1,877,389	1,387,299
Current liabilities:
Accounts payable and accrued expenses	945,403	343,080
Accrued interest, related party	26,570	20,439
Accrued interest	51,530
Related party accounts payable and accrued expenses	208,370	102,856
Related party notes payable	73,500	73,500
Convertible debentures, net	1,455,804
Billings in excess of costs and estimated earnings on uncompleted contracts	26,999	69,789
Deferred revenue	438,859	201,117
Conversion option liabilities	14,152	69,502
Warrant liabilities	271,459	337,055
Total current liabilities	3,512,646	1,217,338
Convertible debentures, net	229,086	685,692
Total liabilities	3,741,732	1,903,030
Commitments
Stockholders' deficiency:
Preferred stock, $0.01 par value, 5,000,000 shares authorized; 0 issued and outstanding at September 30, 2013 and December 31, 2012
Common stock, $0.01 par value, 100,000,000 shares authorized; 42,198,093 issued and outstanding at September 30, 2013 and December 31, 2012	421,981	421,981
Additional paid-in capital	6,408,010	6,099,635
Accumulated deficiency	(8,689,394)	(7,036,776)
Accumulated other comprehensive loss	(4,940)	(571)
Total stockholders' deficiency	(1,864,343)	(515,731)
Totals	$ 1,877,389	$ 1,387,299